PHAXIAM Therapeutics S.A. (LON: 0QSS)
London
· Delayed Price · Currency is GBP · Price in EUR 1.820
+0.070 (4.00%)
Jan 21, 2025, 8:50 AM BST
PHAXIAM Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | - | -23.49 | -0.23 | -53.8 | -73.3 | -62.66 | Upgrade
|
| Depreciation & Amortization | - | 1.22 | 2.91 | 5.38 | 4.99 | 3.16 | Upgrade
|
| Other Amortization | - | - | - | 1.57 | 1.68 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.11 | -23.89 | 0.02 | 0.02 | 0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -0.43 | 1.71 | - | - | 1.04 | Upgrade
|
| Stock-Based Compensation | - | 0.69 | 0.45 | 1.32 | 1.18 | 1.36 | Upgrade
|
| Other Operating Activities | - | -0.47 | -4.61 | -4.1 | 2.9 | 0 | Upgrade
|
| Change in Accounts Receivable | - | 0.22 | -0.06 | -0.01 | 0.03 | -0.01 | Upgrade
|
| Change in Inventory | - | - | - | - | 0.36 | 1.04 | Upgrade
|
| Change in Accounts Payable | - | -1.21 | -9.22 | -6.48 | 6.91 | 5.99 | Upgrade
|
| Change in Other Net Operating Assets | - | -1.08 | 1.19 | -0.67 | 3.5 | 6.71 | Upgrade
|
| Operating Cash Flow | - | -24.43 | -31.76 | -56.77 | -51.72 | -43.31 | Upgrade
|
| Capital Expenditures | - | -0.22 | -0.09 | -0.3 | -1.14 | -20.12 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.02 | 37.63 | - | 0.08 | - | Upgrade
|
| Divestitures | - | 0.01 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -0 | -0.02 | Upgrade
|
| Investment in Securities | - | 0.36 | 0.58 | -0.05 | -0.42 | 0.3 | Upgrade
|
| Other Investing Activities | - | -0 | - | - | - | - | Upgrade
|
| Investing Cash Flow | - | 0.17 | 38.13 | -0.35 | -1.48 | -19.84 | Upgrade
|
| Long-Term Debt Issued | - | - | 3.08 | 12.16 | 27.32 | 1.9 | Upgrade
|
| Long-Term Debt Repaid | - | -3.78 | -4.63 | -1.7 | -1.68 | -1.72 | Upgrade
|
| Net Debt Issued (Repaid) | - | -3.78 | -1.55 | 10.46 | 25.65 | 0.19 | Upgrade
|
| Issuance of Common Stock | - | - | - | 34.63 | 0.12 | - | Upgrade
|
| Other Financing Activities | - | 0.06 | -0.22 | -0.37 | -0.31 | -0.15 | Upgrade
|
| Financing Cash Flow | - | -3.72 | -1.77 | 44.71 | 25.45 | 0.04 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.34 | 0.5 | 1.66 | -0.98 | 1.91 | Upgrade
|
| Net Cash Flow | - | -28.32 | 5.09 | -10.75 | -28.73 | -61.2 | Upgrade
|
| Free Cash Flow | - | -24.65 | -31.85 | -57.07 | -52.86 | -63.43 | Upgrade
|
| Free Cash Flow Margin | - | -1858.60% | -479.13% | -1365.26% | -1421.71% | -1200.59% | Upgrade
|
| Free Cash Flow Per Share | - | -5.25 | -10.27 | -24.09 | -28.75 | -35.36 | Upgrade
|
| Cash Income Tax Paid | - | 0.29 | 0 | 0 | - | - | Upgrade
|
| Levered Free Cash Flow | - | -9.69 | -20.02 | -37.3 | -27.29 | -50.03 | Upgrade
|
| Unlevered Free Cash Flow | - | -9.57 | -19.82 | -37.53 | -27.62 | -49.72 | Upgrade
|
| Change in Net Working Capital | - | -1.14 | 7.18 | 8.61 | -10.33 | -5.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.